High-Body-Mass Patient, High Singles, and a Proposed Repeat FDG Injection
An 82-year-old man weighing 152 kg (BMI 48) is scheduled for staging FDG PET/CT for newly diagnosed lung cancer. The department uses a 3D-mode scanner with a 20-cm axial field of view and a measured NECR peak at 12 kBq/mL. The patient received 555 MBq (15 mCi) of F-18 FDG 60 minutes ago. His blood glucose is 104 mg/dL. The technologist begins a whole-body acquisition at 2 minutes per bed position. The first bed position over the liver shows intense random-coincidence noise and a measured singles rate of 92 Mcps, well above the scanner's recommended maximum of 65 Mcps. The technologist suggests repeating the injection with 740 MBq and scanning immediately to improve count statistics. The patient is uncomfortable and has limited IV access.
1. Is the proposed repeat injection with 740 MBq appropriate? Explain using dead-time, randoms, and count-rate principles.
Read the worked answer
No. Increasing the injected activity from 555 MBq to 740 MBq would raise the singles rate further above the scanner's recommended maximum and would not improve image quality in a predictable way.
In 3D PET, the noise-equivalent count rate (NECR) is approximately proportional to trues²/(trues + scatter + randoms). At high count rates, randoms and dead time grow faster than trues. A 33% activity increase can produce disproportionately more randoms and greater detector dead time, lowering NECR despite more injected tracer. The 92 Mcps singles rate already indicates that the scanner is outside its optimal count-rate range. Repeating the injection also adds radiation burden, delays the study, and consumes limited IV access. The better response is to optimize the acquisition already in progress, not to add activity.
2. What acquisition and reconstruction changes would you make to improve image quality without repeating the dose?
Read the worked answer
First, extend the per-bed acquisition time from 2 minutes to 4–5 minutes. In a large patient, count-limited images improve with longer acquisition because trues accumulate linearly while randoms also accumulate, but the trues fraction improves when the activity is not increased. Second, ensure the patient's arms are positioned to minimize attenuation and scatter, and confirm that the IV site is not infiltrated. Third, use the scanner's time-of-flight and point-spread-function reconstructions if available; these improve lesion detectability in high-BMI patients. Fourth, apply appropriate random-correction and dead-time correction, and review the sinograms for excessive randoms. Fifth, avoid unnecessary bed overlap that increases whole-body time. If the liver bed remains noisy, consider a focused reacquisition over the thorax rather than a whole-body repeat.
3. How should patient weight and scanner count-rate limits influence the FDG dosing decision in future large patients?
Read the worked answer
Weight-based dosing must be balanced against the scanner's NECR curve. A typical oncology dose is 3–5 MBq/kg, but for a 152-kg patient a strict weight-based dose could exceed the scanner's count-rate optimum and worsen image quality through randoms and dead time. The practical approach is to use the scanner's measured NECR peak and local protocol to select a dose that keeps singles below the recommended maximum, then compensate for patient attenuation with longer bed times and optimized reconstruction. The dose should not be increased simply because the patient is large; the count-rate limit and image-noise trade-off must be evaluated together. Document the selected dose and acquisition adjustments.